These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4807159)

  • 21. Effects of exogenous vitamin C on ethanol toxicity in rats.
    Suresh MV; Menon B; Indira M
    Indian J Physiol Pharmacol; 2000 Oct; 44(4):401-10. PubMed ID: 11214494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proposed biotherapy of hyperlipidemia].
    Girotto T; Longo O
    Clin Ter; 1981 Mar; 96(6):393-604. PubMed ID: 7285525
    [No Abstract]   [Full Text] [Related]  

  • 23. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
    Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of oral glucose load on blood lipids and on platelet function].
    Carleo R; Miano P; Sgambato F; Cioffi LA
    Boll Soc Ital Biol Sper; 1980 May; 56(9):853-9. PubMed ID: 7448083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrelationship of dietary lipids and ascorbic acid with hepatic enzymes of cholesterol metabolic pathway.
    Sen S; Mukherjee S
    Indian J Exp Biol; 1997 Jan; 35(1):42-5. PubMed ID: 9279132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolic correlations between blood ascorbic acid, cholet serol and triglycerides in the aged].
    La Rocca L; Greco AM; D'aponte D; Bozza P
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2344-50. PubMed ID: 610756
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study on the interactions between ditazol and anticoagulants in patients with intracardiac valvular prostheses].
    Jacovella G; Milazzotto F
    Clin Ter; 1977 Mar; 80(5):425-31. PubMed ID: 15765
    [No Abstract]   [Full Text] [Related]  

  • 28. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
    Mukherjee D; Mahaffey KW; Moliterno DJ; Harrington RA; Yadav JS; Pieper KS; Gallup D; Dyke C; Roe MT; Berdan L; Lauer MS; Mänttäri M; White HD; Califf RM; Topol EJ
    Am Heart J; 2002 Dec; 144(6):995-1002. PubMed ID: 12486423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of antioxidant efficacy of vitamin E, vitamin C, vitamin A and fruits in coronary heart disease: a controlled trial.
    Singhal S; Gupta R; Goyle A
    J Assoc Physicians India; 2001 Mar; 49():327-31. PubMed ID: 11291971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tolerance to physical exercise in patients with chronic coronary insufficiency treated with anticoagulants].
    Gritsiuk AI; Kucheriavyĭ PG; Terno VS
    Ter Arkh; 1982; 54(3):49-51. PubMed ID: 7089886
    [No Abstract]   [Full Text] [Related]  

  • 31. The myth of anticoagulant prophylaxis in myocardial infarction.
    Russek HI
    Geriatrics; 1971 Jul; 26(7):116-7. PubMed ID: 5088534
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of ascorbic acid on total and high density lipoprotein cholesterol of plasma in normal human subjects.
    Joshi VD; Joshi LN; Gokhale LV
    Indian J Physiol Pharmacol; 1981; 25(4):348-50. PubMed ID: 7341462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effects of cholesterol-lowering therapy on the results of coronary arterial stenting in patients with chronic forms of coronary heart disease].
    Arablinskiĭ AV; Zakharova OV; Ioseliani DG
    Klin Med (Mosk); 2006; 84(7):13-6. PubMed ID: 16924793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anticoagulation therapy in the prevention of chronic coronary insufficiency (according to polyclinic data)].
    Gofman LI; Markelova ZI
    Sov Med; 1971 Oct; 34(10):83-8. PubMed ID: 5137148
    [No Abstract]   [Full Text] [Related]  

  • 35. Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid.
    Widlansky ME; Biegelsen ES; Hamburg NM; Duffy SJ; Keaney JF; Vita JA
    Free Radic Biol Med; 2004 Jan; 36(1):123-30. PubMed ID: 14732296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Side effects of anticoagulant treatment].
    Procházka J
    Vnitr Lek; 1971 Oct; 17(10):1007-15. PubMed ID: 5110474
    [No Abstract]   [Full Text] [Related]  

  • 37. Diabetes and atherosclerosis.
    Woolf N
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():14-42. PubMed ID: 5146903
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blood coagulation system and liver function in patients with chronic coronary insufficiency, continuously taking for a long time anticoagulants of indirect action].
    Zhukov NA; Potashov DA
    Sov Med; 1972 Aug; 35(8):152-4. PubMed ID: 5070537
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholesterol, platelets adhesiveness and fibrinolytic activity in ischaemic heart disease.
    Gupta KK
    J Assoc Physicians India; 1969 May; 17(5):323-31. PubMed ID: 5350177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.